NMR-guided isolation of alkaloids from Nigella glandulifera seeds and their bioactivities
Tuernisan Tudi1, Ruxianguli Rouzimaimaiti2, Deng Zang2
1State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, and Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, China; University of Chinese Academy of Sciences, Beijing, 100039, China.
Abstract:
NMR-guided investigation of Nigella glandulifera Freyn et Sint seeds led to the isolation and characterization of 11 previously undescribed alkaloids, designated nigelladine D-N (1-11). These include three skeletons: (+)/(-)-nigelladine D (1a/1b), and nigelladine E-F (2-3); three piperidines: nigelladine G (4), (+)/(-)-nigelladine H (5a/5b), and nigelladine I (6); three indole alkaloids: (+)/(-)-nigelladine J (7a/7b) and nigelladine K-L (8-9); as well as two pyrrole alkaloids: nigelladine M-N (10-11). In addition, three known 1,4-diazaindane-type pyrrole alkaloids were obtained: agrocybenine (12), the enantiomeric pairs (±)-flavascensine (13a/13b), and (±)-howlumine (14a/14b). Their structures were elucidated using 1D and 2D NMR (Nuclear Magnetic Resonance) spectroscopic analyses, electronic circular dichroism (ECD), quantum chemical calculations, and single-crystal X-ray diffraction (Cu Kα) analysis. Nigelladine D (1) skeleton arises from a piperidine ring and a pyrrole ring fusion through a shared nitrogen atom. Nigelladine E (2) exhibits an unprecedented 6/6/6/6 dipiperidine-condensed cyclopentane framework, likely formed through dimerization of two piperidine derivatives, whereas nigelladine F (3) consists of two piperidine units linked by a pyrrole ring. Furthermore, all compounds exhibited weak inhibitory activity against phosphodiesterase 5 (PDE5) and menin-mixed lineage leukemia 1 (menin-MLL1) protein-protein interaction. Compound 2 significantly increased the melanin content, comparable to that of the positive control 8-methoxypsoralen (8-MOP) (134.50 ± 3.91 % and 134.80 ± 10.24 %, respectively).


